4,4-双丙基环己酮 | 60729-41-1

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 4,4-双丙基环己酮
• 中文别名: 4,4-二-N-丙基环己烯酮
• 英文名称: 4,4-dipropylcyclohex-2-en-1-one
• 英文别名: 4,4-dipropyl-2-cyclohexenone
• CAS: 60729-41-1
• 化学式: C₁₂H₂₀O
• mdl: MFCD00269983
• 分子量: 180.29
• InChiKey: HKTMYZCCZPTLFL-UHFFFAOYSA-N

物化性质

• 沸点：
  60-61°C/0.5 mm
• 溶解度：
  氯仿（微溶）、乙酸乙酯（微溶）

计算性质

• 辛醇/水分配系数(LogP)：
  3.9
• 重原子数：
  13
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.75
• 拓扑面积：
  17.1
• 氢给体数：
  0
• 氢受体数：
  1

安全信息

• 海关编码：
  2914299000

反应信息

• 作为反应物：
  描述：

  4,4-双丙基环己酮 在 palladium on activated charcoal 乙酸铵 、 盐酸 、 lithium aluminium tetrahydride 、 水 、 氢气 、 乙酸酐 、 溶剂黄146 作用下， 以 乙醚 、 乙醇 、 水 、 乙酸乙酯 、 甲苯 为溶剂， 25.0 ℃ 、344.73 kPa 条件下， 反应 101.0h， 生成 2-(3-哌啶-1-基丙基)-8,8-二丙基-2-氮杂螺[4.5]癸烷
  参考文献：
  名称：

  Antiarthritic and supressor cell inducing activity of azaspiranes: structure-function relationships of a novel class of immunomodulatory agents

  摘要：

  Spirogermanium (1; 8,8-diethyl-N,N-dimethyl-2-aza-8- germaspiro[4.5]decane-2-propanamine dihydrochloride) is a potent cytotoxic agent in vitro which has demonstrated limited activity in experimental animal tumor models. Subsequently, it has been reported that spirogermanium has antiarthritic and suppressor cell-inducing activity. We have synthesized a series of substituted 8-hetero-2-azaspiro[4.5]decane and 9-hetero-3-azaspiro[5.5]undecane analogues of spirogermanium to identify the heteroatom requirements for in vivo antiarthritic and suppressor cell-inducing activity. This structure-activity relationship study has identified that appropriately substituted silicon and carbon analogues of spirogermanium retain both antiarthritic and immunosuppressive activity, with the 8,8-dipropyl (carbon) analogue being among the most active. Following the identification of N,N-dimethyl-8,8-dipropyl-2-azaspiro[4.5]decane-2-propanamine++ + dihydrochloride (9) as a more active analogue than spirogermanium, a series of 8,8-dipropyl analogues with various amine substituents were synthesized. A number of these analogues had activity similar to that of 9. A correlation between activity in the adjuvant arthritic rat and the ability to induce suppressor cells (r = 0.894, p less than 0.001) suggests an association between the two pharmacologic effects. While the precise biochemical mechanism(s) for the pharmacological activity is unclear, these data suggest that compounds within this series, e.g., N,N-dimethyl-8,8-dipropyl-2-azaspiro[4.5]decane-2-propanamine++ + dihydrochloride, may provide effective therapy in diseases of autoimmune origin and/or the prevention of rejection in tissue transplantation.

  DOI：

  10.1021/jm00173a010
• 作为产物：
  描述：

  2,2-二丙基环氧乙烷 、 2-丙基戊醛 在 硫酸 作用下， 以 苯 为溶剂， 反应 10.0h， 以68%的产率得到4,4-双丙基环己酮
  参考文献：
  名称：

  Antiarthritic and supressor cell inducing activity of azaspiranes: structure-function relationships of a novel class of immunomodulatory agents

  摘要：

  Spirogermanium (1; 8,8-diethyl-N,N-dimethyl-2-aza-8- germaspiro[4.5]decane-2-propanamine dihydrochloride) is a potent cytotoxic agent in vitro which has demonstrated limited activity in experimental animal tumor models. Subsequently, it has been reported that spirogermanium has antiarthritic and suppressor cell-inducing activity. We have synthesized a series of substituted 8-hetero-2-azaspiro[4.5]decane and 9-hetero-3-azaspiro[5.5]undecane analogues of spirogermanium to identify the heteroatom requirements for in vivo antiarthritic and suppressor cell-inducing activity. This structure-activity relationship study has identified that appropriately substituted silicon and carbon analogues of spirogermanium retain both antiarthritic and immunosuppressive activity, with the 8,8-dipropyl (carbon) analogue being among the most active. Following the identification of N,N-dimethyl-8,8-dipropyl-2-azaspiro[4.5]decane-2-propanamine++ + dihydrochloride (9) as a more active analogue than spirogermanium, a series of 8,8-dipropyl analogues with various amine substituents were synthesized. A number of these analogues had activity similar to that of 9. A correlation between activity in the adjuvant arthritic rat and the ability to induce suppressor cells (r = 0.894, p less than 0.001) suggests an association between the two pharmacologic effects. While the precise biochemical mechanism(s) for the pharmacological activity is unclear, these data suggest that compounds within this series, e.g., N,N-dimethyl-8,8-dipropyl-2-azaspiro[4.5]decane-2-propanamine++ + dihydrochloride, may provide effective therapy in diseases of autoimmune origin and/or the prevention of rejection in tissue transplantation.

  DOI：

  10.1021/jm00173a010

文献信息

• N-substituted phenylacetamide derivative and pharmaceutical composition containing the same
  申请人：Morie Toshiya

  公开号：US20090082463A1

  公开（公告）日：2009-03-26

  The invention provides the following compound (I): wherein R 1 is methoxy group, hydroxyl group or hydrogen atom; R 2 is hydrogen atom, C 1-4 alkyl group, C 1-4 alkylcarbonyl group or arylcarbonyl group; D is a group of the following formula (A), (B), or (C). The compound is useful as a medicament for treating neuropathic pain or pain caused by various diseases such as rheumatoid arthritis and osteoarthritis, and inflammation.

  本发明提供以下化合物（I）：其中，R1是甲氧基、羟基或氢原子；R2是氢原子、C1-4烷基、C1-4烷基羰基或芳基羰基；D是下式（A）、（B）或（C）的基团。该化合物可用作治疗神经病理性疼痛或由风湿性关节炎和骨关节炎等各种疾病引起的疼痛和炎症的药物。
• N-substituted phenylacetamide derivative and pharmaceutical composition containing the same
  申请人：Dainippon Sumitomo Pharma Co., Ltd.

  公开号：US07767854B2

  公开（公告）日：2010-08-03

  The invention provides the following compound (I): wherein R1 is methoxy group, hydroxyl group or hydrogen atom; R2 is hydrogen atom, C1-4 alkyl group, C1-4 alkylcarbonyl group or arylcarbonyl group; D is a group of the following formula (A), (B), or (C). The compound is useful as a medicament for treating neuropathic pain or pain caused by various diseases such as rheumatoid arthritis and osteoarthritis, and inflammation.

  本发明提供以下化合物(I)：其中R1是甲氧基、羟基或氢原子；R2是氢原子、C1-4烷基、C1-4烷基羰基或芳基羰基；D是以下公式(A)、(B)或(C)的基团。该化合物可用作治疗神经病性疼痛或由类风湿性关节炎和骨关节炎等各种疾病引起的疼痛和炎症的药物。
• Ruthenium‐Catalyzed Activation of Nonpolar C−C Bonds via π‐Coordination‐Enabled Aromatization
  作者：Lun Xu、Hang Shi

  DOI：10.1002/anie.202307285

  日期：2023.8.21

  Activation of C−C bonds allows editing of molecular skeletons, but methods for selective activation of nonpolar C−C bonds in the absence of a chelation effect or a driving force derived from opening of a strained ring are scarce. Herein, we report a method for ruthenium‐catalyzed activation of nonpolar C−C bonds of pro‐aromatic compounds by means of π‐coordination‐enabled aromatization. This method was effective for cleavage of C−C(alkyl) and C−C(aryl) bonds and for ring‐opening of spirocyclic compounds, providing an array of benzene‐ring‐containing products. The isolation of a methyl ruthenium complex intermediate supports a mechanism involving ruthenium‐mediated C−C bond cleavage.

  摘要 C-C 键的活化可以编辑分子骨架，但在没有螯合效应或打开应变环产生的驱动力的情况下，选择性活化非极性 C-C 键的方法却很少。在此，我们报告了一种通过 π 配位促成的芳香化作用，在钌催化下活化原芳香族化合物非极性 C-C 键的方法。这种方法对 C-C（烷基）键和 C-C（芳基）键的裂解以及螺环化合物的开环非常有效，可提供一系列含苯环的产物。甲基钌络合物中间体的分离支持了钌介导的 C-C 键裂解机制。
• N-SUBSTITUTED PHENYLACETAMIDE DERIVATIVE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
  申请人：Dainippon Sumitomo Pharma Co., Ltd.

  公开号：EP1884510A1

  公开（公告）日：2008-02-06

  The invention provides the following compound (I): wherein R1 is methoxy group, hydroxyl group or hydrogen atom; R2 is hydrogen atom, C1-4 alkyl group, C1-4 alkylcarbonyl group or arylcarbonyl group; D is a group of the following formula (A), (B), or (C). The compound is useful as a medicament for treating neuropathic pain or pain caused by various diseases such as rheumatoid arthritis and osteoarthritis, and inflammation.

  本发明提供了以下化合物 (I)： 其中 R1 是甲氧基、羟基或氢原子；R2 是氢原子、C1-4 烷基、C1-4 烷基羰基或芳基羰基；D 是下式（A）、（B）或（C）的基团。 该化合物可用作治疗神经性疼痛或各种疾病（如类风湿性关节炎和骨关节炎）和炎症引起的疼痛的药物。
• WO2006/115168
  申请人：——

  公开号：——

  公开（公告）日：——